- Home
- ESLT vs QGEN Comparison
ESLT vs QGEN Comparison
Compare ESLT & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLT
- QGEN
- Stock Information
- Founded
- ESLT 1966
- QGEN 1986
- Country
- ESLT Israel
- QGEN Netherlands
- Employees
- ESLT N/A
- QGEN N/A
- Industry
- ESLT Military/Government/Technical
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ESLT Industrials
- QGEN Health Care
- Exchange
- ESLT Nasdaq
- QGEN Nasdaq
- Market Cap
- ESLT 11.7B
- QGEN 9.5B
- IPO Year
- ESLT 1996
- QGEN 1996
- Fundamental
- Price
- ESLT $257.78
- QGEN $44.67
- Analyst Decision
- ESLT
- QGEN Buy
- Analyst Count
- ESLT 0
- QGEN 9
- Target Price
- ESLT N/A
- QGEN $51.42
- AVG Volume (30 Days)
- ESLT 46.3K
- QGEN 865.8K
- Earning Date
- ESLT 11-19-2024
- QGEN 02-04-2025
- Dividend Yield
- ESLT 0.78%
- QGEN 2.96%
- EPS Growth
- ESLT N/A
- QGEN N/A
- EPS
- ESLT 5.85
- QGEN 0.41
- Revenue
- ESLT $6,523,449,000.00
- QGEN $1,966,174,000.00
- Revenue This Year
- ESLT $10.97
- QGEN $2.78
- Revenue Next Year
- ESLT $4.93
- QGEN $5.69
- P/E Ratio
- ESLT $44.40
- QGEN $107.74
- Revenue Growth
- ESLT 11.41
- QGEN 0.62
- 52 Week Low
- ESLT $175.30
- QGEN $39.03
- 52 Week High
- ESLT $266.35
- QGEN $47.44
- Technical
- Relative Strength Index (RSI)
- ESLT 61.10
- QGEN 54.59
- Support Level
- ESLT $257.43
- QGEN $44.02
- Resistance Level
- ESLT $263.60
- QGEN $46.08
- Average True Range (ATR)
- ESLT 4.30
- QGEN 0.76
- MACD
- ESLT -0.11
- QGEN -0.03
- Stochastic Oscillator
- ESLT 62.48
- QGEN 41.98
About ESLT Elbit Systems Ltd.
Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security, and commercial flight capabilities. Its systems and solutions may be installed on new platforms, or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company markets its systems and products as a prime contractor or as a subcontractor to government, defense, and homeland security contractors world wide.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).